Literature DB >> 27562567

Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis.

N Singh Ospina1,2, S Maraka1,2, R Rodriguez-Gutierrez2,3, A E Espinosa de Ycaza1, S Jasim1, M Gionfriddo2,4, A Castaneda-Guarderas2,5, J P Brito1,2, A Al Nofal6,7, P Erwin8, R Wermers1, V Montori9,10.   

Abstract

Counseling for patients with primary hyperparathyroidism (PHPT) and mild hypercalcemia without indications for surgical intervention requires accurate estimates of the potential benefits of parathyroidectomy. We aim to summarize the available evidence regarding the benefits of parathyroidectomy that patients with mild PHPT without indications for surgery experience compared to observation. We searched multiple databases from inception to August 2015. We included randomized controlled trials (RCT) and observational studies that evaluated changes in bone health, quality of life or neuropsychiatric symptoms, or in the risk of nephrolithiasis, cardiovascular events, or death between patients undergoing parathyroidectomy or active surveillance. Eight studies were eligible. Risk differences were not significant, in part due to lack of events (fractures, nephrolithiasis, cardiovascular events, or deaths). No significant differences were observed across measures of bone health, quality of life, and neuropsychiatric symptoms. A single RCT evaluating bone mineral density (BMD) changes at 5 years found a small statistically significant effect favoring parathyroidectomy. Patients with mild PHPT without indications for surgery experience a limited number of adverse consequences during short-term follow-up limiting our ability to estimate the benefit of surgery during this timeframe. This information is helpful as these patients consider surgery versus active surveillance. Long-term data is warranted to determine who benefits in the long run from surgical intervention and the extent to which this benefit affects outcomes that matter to patients.

Entities:  

Keywords:  Bone mineral density; Hypercalcemia; Parathyroidectomy; Primary hyperparathyroidism; Surveillance

Mesh:

Year:  2016        PMID: 27562567     DOI: 10.1007/s00198-016-3715-3

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  44 in total

1.  The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism.

Authors:  Robert Udelsman; Zhenqiu Lin; Patricia Donovan
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

2.  Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  D Nakaoka; T Sugimoto; T Kobayashi; T Yamaguchi; A Kobayashi; K Chihara
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

3.  Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism.

Authors:  A B Grey; J P Stapleton; M C Evans; I R Reid
Journal:  Clin Endocrinol (Oxf)       Date:  1996-06       Impact factor: 3.478

4.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

5.  Forearm bone density in primary hyperparathyroidism: long-term follow-up with and without parathyroidectomy.

Authors:  D Sudhaker Rao; Elizabeth A Wallace; Rosella F Antonelli; Gary B Talpos; Mohammed R Ansari; Gordon Jacobsen; George W Divine; A Michael Parfitt
Journal:  Clin Endocrinol (Oxf)       Date:  2003-03       Impact factor: 3.478

Review 6.  Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis.

Authors:  Shyam Sankaran; Greg Gamble; Mark Bolland; Ian R Reid; Andrew Grey
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

Review 7.  A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003.

Authors:  James M Ruda; Christopher S Hollenbeak; Brendan C Stack
Journal:  Otolaryngol Head Neck Surg       Date:  2005-03       Impact factor: 3.497

8.  Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Authors:  Jens Bollerslev; Svante Jansson; Charlotte L Mollerup; Jörgen Nordenström; Eva Lundgren; Ove Tørring; Jan-Erik Varhaug; Marek Baranowski; Sylvi Aanderud; Celina Franco; Bo Freyschuss; Gunhild A Isaksen; Thor Ueland; Thord Rosen
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

9.  Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism.

Authors:  M Abdelhadi; J Nordenström
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

10.  Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism.

Authors:  Susan M Webb; Manel Puig-Domingo; Carles Villabona; Manuel Muñoz-Torres; Jordi Farrerons; Xavier Badia
Journal:  Health Qual Life Outcomes       Date:  2013-06-18       Impact factor: 3.186

View more
  10 in total

Review 1.  Primary Hyperparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

2.  Persistently Elevated PTH After Parathyroidectomy at One Year: Experience in a Tertiary Referral Center.

Authors:  Marie Caldwell; Jeff Laux; Marshall Clark; Lawrence Kim; Janet Rubin
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 3.  Hypercalcaemia - presentation and management .

Authors:  Jeremy J O Turner
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

4.  Skeletal effects of combined bisphosphonates treatment and parathyroidectomy in osteoporotic patients with primary hyperparathyroidism.

Authors:  Hun Jee Choe; Bo Kyung Koo; Ka Hee Yi; Sung Hye Kong; Jung Hee Kim; Chan Soo Shin; Jee Won Chai; Sang Wan Kim
Journal:  J Bone Miner Metab       Date:  2021-11-10       Impact factor: 2.626

5.  Surgical management of MILD hyperparathyroidism.

Authors:  Adèle Lecourt; Gwenaëlle Creff; Paul Coudert; Olivier De Crouy Chanel; Pascal Guggenbuhl; Franck Jegoux
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-30       Impact factor: 2.503

6.  Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism.

Authors:  Ann E Kearns; Rachel P Espiritu; Kristin Vickers Douglass; Prabin Thapa; Robert A Wermers
Journal:  Clin Endocrinol (Oxf)       Date:  2019-06-25       Impact factor: 3.523

7.  Psychosis in a primary hyperparathyroidism patient with mild hypercalcemia: A case report.

Authors:  Koji Otsuki; Muneto Izuhara; Shoko Miura; Satoko Yamashita; Michiharu Nagahama; Maiko Hayashida; Sadayuki Hashioka; Tsuyoshi Miyaoka; Yukie Hotta; Yasuhiko Shimizu; Masatoshi Inagaki
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

Review 8.  Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review.

Authors:  Julius Simoni Leere; Jesper Karmisholt; Maciej Robaczyk; Peter Vestergaard
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-20       Impact factor: 5.555

9.  The Risk of Fractures in Primary Hyperparathyroidism: A Meta-Analysis.

Authors:  Niya Narayanan; Rajan Palui; Chandhana Merugu; Sitanshu Sekhar Kar; Sadishkumar Kamalanathan; Jayaprakash Sahoo; Sandhiya Selvarajan; Dukhabandhu Naik
Journal:  JBMR Plus       Date:  2021-03-16

10.  Diagnosis and treatment of primary hyperparathyroidism with pathological fracture of the limbs: A retrospective observational study.

Authors:  Huijiang Liu; Kai Luo; Shijie Liao; Haijun Tang; Jianming Mo; Tianyu Xie; Chong Li; Boxiang Li; Yun Liu; Xinli Zhan
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.